European Patent Office

T 1328/20 (Endoxifen / JINA PHARMACEUTICALS) of 06.04.2023

European Case Law Identifier
ECLI:EP:BA:2023:T132820.20230406
Date of decision
6 April 2023
Case number
T 1328/20
Petition for review of
-
Application number
07871563.8
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
ENDOXIFEN FOR USE IN THE TREATMENT OF CANCER
Applicant name
Jina Pharmaceuticals Inc.
Opponent name
Besins Healthcare Monaco S.A.M
Bayer Intellectual Property GmbH / Bayer Aktiengesellschaft
Board
3.3.07
Headnote
-
Relevant legal provisions
European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 013(1)
Keywords
Inventive step - technical prejudice in the art (no)
Amendment to case - suitability of amendment to address issues (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed